» Articles » PMID: 34150360

Capturing Clinical Symptoms with Ecological Momentary Assessment: Convergence of Momentary Reports of Psychotic and Mood Symptoms with Diagnoses and Standard Clinical Assessments

Overview
Date 2021 Jun 21
PMID 34150360
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The development and deployment of technology-based assessments of clinical symptoms are increasing. This study used ecological momentary assessment (EMA) to examine clinical symptoms and relates these sampling results to structured clinical ratings. Three times a day for 30 days, participants with bipolar disorder (n=71; BPI) or schizophrenia (n=102; SCZ) completed surveys assessing five psychosis-related and five mood symptoms, in addition to reporting their location and who they were with at the time of survey completion. Participants also completed Positive and Negative Syndrome Scale (PANSS) interviews with trained raters. Mixed-model repeated-measures (MMRM) analyses examined diagnostic effects and the convergence between clinical ratings and EMA sampling. In total, 12,406 EMA samples were collected, with 80-percent adherence to prompts. EMA-reported psychotic symptoms manifested substantial convergence with equivalent endpoint PANSS items. Patients with SCZ had more severe PANSS and EMA psychotic symptoms. There were no changes in symptom severity scores as a function of the number of previous assessments. EMA surveyed clinical symptoms converged substantially with commonly used clinical rating scales in a large sample, with high adherence. This suggested that remote assessment of clinical symptoms is valid and practical and was not associated with alterations in symptoms as a function of reassessment, with additional benefits of "in the moment" sampling, such as eliminating recall bias and the need for informant reports.

Citing Articles

Feasibility and psychometric quality of smartphone administered cognitive ecological momentary assessments in women with metastatic breast cancer.

Henneghan A, Paolillo E, Van Dyk K, Franco-Rocha O, Bang S, Tasker R Digit Health. 2025; 11:20552076241310474.

PMID: 39758254 PMC: 11696949. DOI: 10.1177/20552076241310474.


The day-to-day influence of trauma exposure and sleep dysfunction on everyday stress in youth at familial high-risk for psychotic disorders.

Haudrich E, Burns E, Gupta T, Haas G, Horton L Schizophr Res. 2024; 274:535-544.

PMID: 39586206 PMC: 11803678. DOI: 10.1016/j.schres.2024.10.024.


Rationale and Challenges for a New Instrument for Remote Measurement of Negative Symptoms.

Daniel D, Cohen A, Harvey P, Velligan D, Potter W, Horan W Schizophr Bull Open. 2024; 5(1):sgae027.

PMID: 39502136 PMC: 11535854. DOI: 10.1093/schizbullopen/sgae027.


Remote Assessment of Negative Symptoms of Schizophrenia.

Daniel D, Cohen A, Velligan D, Harvey P, Alphs L, Davidson M Schizophr Bull Open. 2024; 4(1):sgad001.

PMID: 39145343 PMC: 11207840. DOI: 10.1093/schizbullopen/sgad001.


Digital Neuropsychology beyond Computerized Cognitive Assessment: Applications of Novel Digital Technologies.

Harris C, Tang Y, Birnbaum E, Cherian C, Mendhe D, Chen M Arch Clin Neuropsychol. 2024; 39(3):290-304.

PMID: 38520381 PMC: 11485276. DOI: 10.1093/arclin/acae016.


References
1.
Correll C, Davis R, Weingart M, Saillard J, OGorman C, Kane J . Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial. JAMA Psychiatry. 2020; 77(4):349-358. PMC: 6990963. DOI: 10.1001/jamapsychiatry.2019.4379. View

2.
Khan A, Liharska L, Harvey P, Atkins A, Ulshen D, Keefe R . Negative Symptom Dimensions of the Positive and Negative Syndrome Scale Across Geographical Regions: Implications for Social, Linguistic, and Cultural Consistency. Innov Clin Neurosci. 2018; 14(11-12):30-40. PMC: 5788249. View

3.
Oorschot M, Lataster T, Thewissen V, Wichers M, Myin-Germeys I . Mobile assessment in schizophrenia: a data-driven momentary approach. Schizophr Bull. 2011; 38(3):405-13. PMC: 3330000. DOI: 10.1093/schbul/sbr166. View

4.
Strauss G, Zamani Esfahlani F, Granholm E, Holden J, Visser K, Bartolomeo L . Mathematically Modeling Anhedonia in Schizophrenia: A Stochastic Dynamical Systems Approach. Schizophr Bull. 2020; 46(5):1191-1201. PMC: 7505187. DOI: 10.1093/schbul/sbaa014. View

5.
Ben-Zeev D, Brenner C, Begale M, Duffecy J, Mohr D, Mueser K . Feasibility, acceptability, and preliminary efficacy of a smartphone intervention for schizophrenia. Schizophr Bull. 2014; 40(6):1244-53. PMC: 4193714. DOI: 10.1093/schbul/sbu033. View